Clinical Trial Update: Multicenter Investigation of Limitation of Infarct Size (MILIS) [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial MILIS evaluating strategies to limit infarct size in myocardial infarction has completed enrollment and is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease
• Myocardial Infarction
• Myocardial Ischemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED